The (Unmet) Potential Value of Cancer Genome Testing as seen in Forbes Genome sequencing is not routine in oncology practice. But maybe it should be, advocates suggest. Related Post navigation Previous: ‘Decoding Annie Parker’ Focuses On Women, Breast Cancer And Changing ScienceNext: Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors?